表紙
市場調查報告書
商品編碼
991411

核成像設備的全球市場 (∼2025年):各產品 (SPECT (混合、獨立的)、混合PET、平面閃爍圖術)、用途 (腫瘤、心臟病、神經)、終端用戶 (醫院、成像中心)、地區

Nuclear Imaging Equipment Market by Product (SPECT (Hybrid SPECT, Standalone SPECT), Hybrid PET, & Planar Scintigraphy), Application (Oncology, Cardiology & Neurology) & End user (Hospitals, Imaging Centers) - Global Forecasts to 2025

出版日期: | 出版商: MarketsandMarkets | 英文 130 Pages | 訂單完成後即時交付

價格
  • 全貌
  • 簡介
  • 目錄
簡介

核成像設備的市場規模在預測期間內預計以3.9%的年複合成長率發展,從2020年的38億美元,成長到2025年46億美元的規模。從獨立轉向混合模式,放射性描繪器的進步,個人化醫療的關注高漲,影像診斷中心的現代化的公民營聯盟的投資,癌症的發生率、盛行率增加等要素促進該市場的成長。

本報告提供全球核成像設備的市場調查,市場定義和概要,價值鏈,新型冠狀病毒感染疾病 (COVID-19) 以及其他的市場影響因素分析,價格趨勢,市場規模的變化、預測,產品、用途、終端用戶、地區/主要國家等各種區分的明細,競爭環境,主要企業簡介等資訊彙整。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

第5章 市場概要

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 課題
  • 價格分析
  • 波特的五力分析
  • COVID-19乘坐的影響
  • 價值鏈分析
  • 供應鏈分析

第6章 市場分析、預測:各產品

  • SPECT成像系統
    • 混合SPECT成像系統
    • 獨立的SPECT成像系統
  • 混合PET成像系統
  • 平面閃爍檢查成像系統

第7章 市場分析、預測:各用途

  • 腫瘤
  • 心臟病
  • 神經
  • 其他

第8章 市場分析、預測:各終端用戶

  • 醫院
  • 成像中心
  • 學術、研究中心
  • 其他

第9章 市場分析、預測:各地區、主要國家

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • EU3
    • 俄羅斯
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 其他
  • 其他地區

第10章 競爭情形

  • 概要
  • 市場佔有率分析
  • 競爭領導製圖
  • 競爭模式

第11章 企業簡介

  • SIEMENS HEALTHINEERS
  • GE HEALTHCARE
  • KONINKLIJKE PHILIPS N.V.
  • DIGIRAD CORPORATION
  • NEUSOFT MEDICAL SYSTEMS CO., LTD.
  • CANON INC.
  • SURGICEYE GMBH
  • DDD-DIAGNOSTIC A/S
  • CMR NAVISCAN CORPORATION
  • MEDISO LTD.
  • SHIMADZU CORPORATION
  • PERKINELMER, INC.
  • MILABS B.V.
  • MR SOLUTIONS LTD.

第12章 附錄

目錄
Product Code: MD 1010

The nuclear imaging equipment market is expected to reach USD 4.6 billion by 2025 from USD 3.8 billion in 2020, at a CAGR of 3.9% during the forecast period.

Growth in the market can primarily be attributed to factors such as shift from standalone to hybrid modalities, advances in radiotracers, the increasing focus on personalized medicine, investments through public-private partnerships to modernize diagnostic imaging centers, and the increasing incidence and prevalence of cancer and cardiac ailments.

"The SPECT imaging systems segment to hold the largest market share in 2020."

Based on product, the nuclear imaging equipment market is segmented into hybrid PET imaging systems, SPECT imaging systems, and planar scintigraphy imaging systems. The SPECT imaging systems segment is further categorized into standalone and hybrid imaging systems. The SPECT imaging systems segment is expected to the largest share in 2019. The large share of this segment can be attributed to high adoption of SPECT imaing systems on account of lower cost as compared to hybrid PET imaging systems.

"The oncology segment to hold the largest market share in 2020."

Based on application, the nuclear imaging equipment market is segmented into oncology, cardiology, neurology, and other applications. The oncology application segment is expected to register the highest CAGR during the forecast period. The major factors contributing to the growth of this segment include the rising incidence and prevalence of cancer across the globe, initiatives taken by public and private organizations to curb the rising cancer prevalence, and the development of advanced systems and radiotracers for oncology.

"The hospitals segment to hold the largest market share in 2020."

Based on end user, the nuclear imaging equipment market is segmented into hospitals, imaging centers, academic & research centers, and other end users. Hospitals accounted for the largest share of the global nuclear imaging equipment market in 2019. This can be attributed to factors such as the need to improve the efficiency of diagnostic imaging procedures and the rising number of diagnostic imaging procedures performed in hospitals.

"The Asia Pacific region to witness the highest growth during the forecast period."

Geographically, North America dominated the global nuclear imaging equipment market in 2020. However, the Asia Pacific market is expected to register the highest during the forecast period. The major factors driving the growth of the Asia Pacific market include increasing incidence of chronic diseases, rising awareness on the benefits of early disease diagnosis, and improvement of healthcare systems in the region.

Break of primary participants was as mentioned below:

  • By Company Type: Tier I: 40%, Tier II: 30%, Tier III: 30%
  • By Designation: C-Level Executives: 27%, Directors: 18%, Others: 55%
  • By Region: North America: 40%, Europe: 20%, Asia Pacific : 30%, Latin America: 8%, Middle-East: 2%

Siemens Healthineers (Germany), GE Healthcare (US), and Philips Healthcare (Netherlands). were the leading players in the nuclear imaging equipment market.

Research Coverage

This report studies the nuclear imaging equipment market based on product, application, end-user, and region. The report also studies the different factors (such as drivers, restraints, challenges, and opportunities) affecting the market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions and respective countries.

Key Benefits of Buying the Report

This report focuses on various levels of analysis-industry trends, market shares of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the nuclear imaging equipment market, and their drivers, restraints, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the nuclear imaging equipment market and garner greater market shares.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
    • 1.2.2 MARKETS COVERED
    • FIGURE 1 NUCLEAR IMAGING EQUIPMENT MARKET SEGMENTATION
    • 1.2.3 YEARS CONSIDERED FOR THE STUDY
  • 1.3 CURRENCY
  • 1.4 LIMITATIONS
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
  • 2.2 RESEARCH METHODOLOGY STEPS
    • FIGURE 2 RESEARCH METHODOLOGY: NUCLEAR IMAGING EQUIPMENT MARKET
    • FIGURE 3 RESEARCH DESIGN
    • 2.2.1 SECONDARY DATA
      • 2.2.1.1 Key data from secondary sources
    • 2.2.2 PRIMARY DATA
    • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    • FIGURE 5 PRIMARY SOURCES
      • 2.2.2.1 Key data from primary sources
  • 2.3 MARKET SIZE ESTIMATION METHODOLOGY
    • FIGURE 6 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
    • FIGURE 7 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
  • 2.4 MARKET DATA ESTIMATION AND TRIANGULATION
    • FIGURE 8 DATA TRIANGULATION METHODOLOGY
  • 2.5 ASSUMPTIONS FOR THE STUDY
  • 2.6 COVID-19-SPECIFIC ASSUMPTIONS

3 EXECUTIVE SUMMARY

    • FIGURE 9 NUCLEAR IMAGING EQUIPMENT MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)
    • FIGURE 10 NUCLEAR IMAGING EQUIPMENT MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
    • FIGURE 11 NUCLEAR IMAGING EQUIPMENT MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
    • FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE NUCLEAR IMAGING EQUIPMENT MARKET

4 PREMIUM INSIGHTS

  • 4.1 NUCLEAR IMAGING EQUIPMENT OVERVIEW
    • FIGURE 13 GROWING POPULARITY OF HYBRID MODALITIES HAS DRIVEN THEIR ADOPTION
  • 4.2 NORTH AMERICA: NUCLEAR IMAGING EQUIPMENT MARKET, BY PRODUCT & COUNTRY (2019)
    • FIGURE 14 US ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN NUCLEAR IMAGING EQUIPMENT IN 2019
  • 4.3 NUCLEAR IMAGING EQUIPMENT MARKET SHARE, BY PRODUCT, 2020 VS. 2025
    • FIGURE 15 SPECT IMAGING SYSTEMS WILL CONTINUE TO DOMINATE THE MARKET IN 2025
  • 4.4 NUCLEAR IMAGING EQUIPMENT MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 16 ASIA PACIFIC TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 17 NUCLEAR IMAGING EQUIPMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Rapidly growing geriatric population and the subsequent increase in the prevalence of associated diseases
    • TABLE 1 AGE-RELATED DISEASES AND ASSOCIATED DIAGNOSTIC MODALITIES
      • 5.2.1.2 Shift from standalone to hybrid modalities
      • 5.2.1.3 Increasing focus on personalized medicine
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High cost of diagnostic imaging systems
      • 5.2.2.2 Declining reimbursements and increasing regulatory burden in the US
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 High growth opportunities in emerging countries
      • 5.2.3.2 Growing demand for data integrated imaging systems
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Hospital budget cuts
  • 5.3 PRICING ANALYSIS
    • TABLE 2 REGIONAL PRICING ANALYSIS OF KEY NUCLEAR IMAGING MODALITIES
  • 5.4 PORTER'S FIVE FORCES ANALYSIS
    • FIGURE 18 PORTER'S FIVE FORCES ANALYSIS
    • 5.4.1 BARGAINING POWER OF BUYERS
    • 5.4.2 BARGAINING POWER OF SUPPLIERS
    • 5.4.3 THREAT OF NEW ENTRANTS
    • 5.4.4 THREAT OF SUBSTITUTES
    • 5.4.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.5 IMPACT OF COVID-19 ON THE NUCLEAR IMAGING EQUIPMENT MARKET
  • 5.6 VALUE CHAIN ANALYSIS
    • FIGURE 19 MAJOR VALUE IS ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASE
    • 5.6.1 RESEARCH & DEVELOPMENT
    • 5.6.2 MANUFACTURING & ASSEMBLY
    • 5.6.3 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES
  • 5.7 SUPPLY CHAIN ANALYSIS
    • 5.7.1 PROMINENT COMPANIES
    • 5.7.2 SMALL & MEDIUM-SIZED ENTERPRISES
    • 5.7.3 END USERS
    • FIGURE 20 DISTRIBUTION-A STRATEGY PREFERRED BY PROMINENT COMPANIES
    • FIGURE 21 ECOSYSTEM ANALYSIS OF THE NUCLEAR IMAGING EQUIPMENT MARKET

6 NUCLEAR IMAGING EQUIPMENT MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
    • TABLE 3 NUCLEAR IMAGING EQUIPMENT MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 4 NUCLEAR IMAGING EQUIPMENT MARKET, BY PRODUCT, 2018-2025 (UNITS)
  • 6.2 SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) IMAGING SYSTEMS
    • TABLE 5 SPECT IMAGING SYSTEMS MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 6 SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 7 SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018-2025 (UNITS)
    • TABLE 8 NORTH AMERICA: SPECT IMAGING SYSTEMS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 9 EUROPE: SPECT IMAGING SYSTEMS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 10 ASIA PACIFIC: SPECT IMAGING SYSTEMS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • 6.2.1 HYBRID SPECT IMAGING SYSTEMS
      • 6.2.1.1 Growing preference for dual-modality hybrid systems to drive market growth
    • TABLE 11 HYBRID SPECT IMAGING SYSTEMS MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 12 NORTH AMERICA: HYBRID SPECT IMAGING SYSTEMS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 13 EUROPE: HYBRID SPECT IMAGING SYSTEMS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 14 ASIA PACIFIC: HYBRID SPECT IMAGING SYSTEMS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • 6.2.2 STANDALONE SPECT IMAGING SYSTEMS
      • 6.2.2.1 Low cost of standalone SPECT imaging systems is a key factor driving market growth
    • TABLE 15 STANDALONE SPECT IMAGING SYSTEMS MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 16 NORTH AMERICA: STANDALONE SPECT IMAGING SYSTEMS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 17 EUROPE: STANDALONE SPECT IMAGING SYSTEMS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 18 ASIA PACIFIC: STANDALONE SPECT IMAGING SYSTEMS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • 6.3 HYBRID PET IMAGING SYSTEMS
    • 6.3.1 HIGH COST OF HYBRID PET IMAGING SYSTEMS TO LIMIT MARKET GROWTH DURING THE FORECAST PERIOD
    • TABLE 19 HYBRID PET IMAGING SYSTEMS MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 20 NORTH AMERICA: HYBRID PET IMAGING SYSTEMS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 21 EUROPE: HYBRID PET IMAGING SYSTEMS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 22 ASIA PACIFIC: HYBRID PET IMAGING SYSTEMS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • 6.4 PLANAR SCINTIGRAPHY IMAGING SYSTEMS
    • 6.4.1 LOW SPECIFICITY OF PLANAR SCINTIGRAPHY IMAGING SYSTEMS TO LIMIT MARKET GROWTH
    • TABLE 23 PLANAR SCINTIGRAPHY IMAGING SYSTEMS MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 24 NORTH AMERICA: PLANAR SCINTIGRAPHY IMAGING SYSTEMS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 25 EUROPE: PLANAR SCINTIGRAPHY IMAGING SYSTEMS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 26 ASIA PACIFIC: PLANAR SCINTIGRAPHY IMAGING SYSTEMS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)

7 NUCLEAR IMAGING EQUIPMENT MARKET, BY APPLICATION

  • 7.1 INTRODUCTION
    • TABLE 27 NUCLEAR IMAGING EQUIPMENT MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 28 SPECT IMAGING SYSTEMS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 29 HYBRID PET IMAGING SYSTEMS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 30 PLANAR SCINTIGRAPHY IMAGING SYSTEMS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • 7.1.1 ONCOLOGY
      • 7.1.1.1 Nuclear imaging systems can distinguish between benign and malignant tumors, which helps in precise diagnosis
    • TABLE 31 NUCLEAR IMAGING EQUIPMENT MARKET FOR ONCOLOGY, BY REGION, 2018-2025 (USD MILLION)
    • 7.1.2 CARDIOLOGY
      • 7.1.2.1 High prevalence of CVD is the major factor driving the growth of this segment
    • TABLE 32 NUCLEAR IMAGING EQUIPMENT MARKET FOR CARDIOLOGY, BY REGION, 2018-2025 (USD MILLION)
    • 7.1.3 NEUROLOGY
      • 7.1.3.1 Increasing demand for nuclear imaging in diagnosing neurological disorders is supporting the growth of this segment
    • TABLE 33 NUCLEAR IMAGING EQUIPMENT MARKET FOR NEUROLOGY, BY REGION, 2018-2025 (USD MILLION)
    • 7.1.4 OTHER APPLICATIONS
    • TABLE 34 NUCLEAR IMAGING EQUIPMENT MARKET FOR OTHER APPLICATIONS, BY REGION, 2018-2025 (USD MILLION)

8 NUCLEAR IMAGING EQUIPMENT MARKET, BY END USER

  • 8.1 INTRODUCTION
    • TABLE 35 NUCLEAR IMAGING EQUIPMENT MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 8.2 HOSPITALS
    • 8.2.1 RISING TREND OF MODERNIZING IMAGING WORKFLOW IS DRIVING THE ADOPTION OF IMAGING SYSTEMS AMONG HOSPITALS
    • TABLE 36 NUCLEAR IMAGING EQUIPMENT MARKET FOR HOSPITALS, BY REGION, 2018-2025 (USD MILLION)
  • 8.3 IMAGING CENTERS
    • 8.3.1 GROWING NUMBER OF PRIVATE IMAGING CENTERS TO SUPPORT MARKET GROWTH
    • TABLE 37 NUCLEAR IMAGING EQUIPMENT MARKET FOR IMAGING CENTERS, BY REGION, 2018-2025 (USD MILLION)
  • 8.4 ACADEMIC & RESEARCH CENTERS
    • 8.4.1 INCREASING COLLABORATIONS BETWEEN NUCLEAR IMAGING COMPANIES AND ACADEMIA TO PROPEL MARKET GROWTH
    • TABLE 38 NUCLEAR IMAGING EQUIPMENT MARKET FOR ACADEMIC & RESEARCH CENTERS, BY REGION, 2018-2025 (USD MILLION)
  • 8.5 OTHER END USERS
    • TABLE 39 NUCLEAR IMAGING EQUIPMENT MARKET FOR OTHER END USERS, BY REGION, 2018-2025 (USD MILLION)

9 NUCLEAR IMAGING EQUIPMENT MARKET, BY REGION

  • 9.1 INTRODUCTION
    • TABLE 40 NUCLEAR IMAGING EQUIPMENT MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 9.2 NORTH AMERICA
    • TABLE 41 NORTH AMERICA: NUCLEAR IMAGING EQUIPMENT MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 42 NORTH AMERICA: NUCLEAR IMAGING EQUIPMENT MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 43 NORTH AMERICA: SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 44 NORTH AMERICA: NUCLEAR IMAGING EQUIPMENT MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 45 NORTH AMERICA: NUCLEAR IMAGING EQUIPMENT MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.2.1 US
      • 9.2.1.1 The US holds the largest share of the North American market
    • TABLE 46 US: NUCLEAR IMAGING EQUIPMENT MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 47 US: SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 48 US: NUCLEAR IMAGING EQUIPMENT MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 49 US: NUCLEAR IMAGING EQUIPMENT MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.2.2 CANADA
      • 9.2.2.1 A dearth of radiologists and long wait times for scans are the major challenges in the Canadian market
    • TABLE 50 CANADA: INDICATORS OF MARKET GROWTH
    • TABLE 51 CANADA: NUCLEAR IMAGING EQUIPMENT MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 52 CANADA: SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 53 CANADA: NUCLEAR IMAGING EQUIPMENT MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 54 CANADA: NUCLEAR IMAGING EQUIPMENT MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 9.3 EUROPE
    • TABLE 55 EUROPE: NUCLEAR IMAGING EQUIPMENT MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 56 EUROPE: NUCLEAR IMAGING EQUIPMENT MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 57 EUROPE: SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 58 EUROPE: NUCLEAR IMAGING EQUIPMENT MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 59 EUROPE: NUCLEAR IMAGING EQUIPMENT MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.3.1 EU3
      • 9.3.1.1 EU3 holds the largest share of the market in Europe
    • TABLE 60 GERMANY: INDICATORS OF MARKET GROWTH
    • TABLE 61 EU3: NUCLEAR IMAGING EQUIPMENT MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 62 EU3: SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 63 EU3: NUCLEAR IMAGING EQUIPMENT MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 64 EU3: NUCLEAR IMAGING EQUIPMENT MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.3.2 RUSSIA
      • 9.3.2.1 Initiatives to improve healthcare to boost the market growth
    • TABLE 65 RUSSIA: NUCLEAR IMAGING EQUIPMENT MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 66 RUSSIA: SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 67 RUSSIA: NUCLEAR IMAGING EQUIPMENT MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 68 RUSSIA: NUCLEAR IMAGING EQUIPMENT MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.3.3 ROE
    • TABLE 69 ROE: NUCLEAR IMAGING EQUIPMENT MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 70 ROE: SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 71 ROE: NUCLEAR IMAGING EQUIPMENT MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 72 ROE: NUCLEAR IMAGING EQUIPMENT MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 9.4 ASIA PACIFIC
    • FIGURE 22 APAC: NUCLEAR IMAGING EQUIPMENT MARKET SNAPSHOT
    • TABLE 73 ASIA PACIFIC: NUCLEAR IMAGING EQUIPMENT MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 74 ASIA PACIFIC: NUCLEAR IMAGING EQUIPMENT MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 75 ASIA PACIFIC: SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 76 ASIA PACIFIC: NUCLEAR IMAGING EQUIPMENT MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 77 ASIA PACIFIC: NUCLEAR IMAGING EQUIPMENT MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.4.1 JAPAN
      • 9.4.1.1 Growing investments by key market players to drive market growth
    • TABLE 78 JAPAN: NUCLEAR IMAGING EQUIPMENT MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 79 JAPAN: SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 80 JAPAN: NUCLEAR IMAGING EQUIPMENT MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 81 JAPAN: NUCLEAR IMAGING EQUIPMENT MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.4.2 CHINA
      • 9.4.2.1 Increasing healthcare reforms and the rapidly growing aging population to drive market growth in China
    • TABLE 82 CHINA: NUCLEAR IMAGING EQUIPMENT MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 83 CHINA: SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 84 CHINA: NUCLEAR IMAGING EQUIPMENT MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 85 CHINA: NUCLEAR IMAGING EQUIPMENT MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.4.3 INDIA
      • 9.4.3.1 Uncertainties in healthcare policies to restrain market growth in India
    • TABLE 86 INDIA: NUCLEAR IMAGING EQUIPMENT MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 87 INDIA: SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 88 INDIA: NUCLEAR IMAGING EQUIPMENT MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 89 INDIA: NUCLEAR IMAGING EQUIPMENT MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.4.4 REST OF ASIA PACIFIC
    • TABLE 90 ROAPAC: NUCLEAR IMAGING EQUIPMENT MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 91 ROAPAC: SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 92 ROAPAC: NUCLEAR IMAGING EQUIPMENT MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 93 ROAPAC: NUCLEAR IMAGING EQUIPMENT MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 9.5 REST OF THE WORLD
    • TABLE 94 ROW: NUCLEAR IMAGING EQUIPMENT MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 95 ROW: SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 96 ROW: NUCLEAR IMAGING EQUIPMENT MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 97 ROW: NUCLEAR IMAGING EQUIPMENT MARKET, BY END USER, 2018-2025 (USD MILLION)

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
    • FIGURE 23 KEY DEVELOPMENTS IN THE NUCLEAR IMAGING EQUIPMENT MARKET
  • 10.2 MARKET SHARE ANALYSIS
    • FIGURE 24 NUCLEAR IMAGING EQUIPMENT MARKET SHARE ANALYSIS (2019)
  • 10.3 COMPETITIVE LEADERSHIP MAPPING
    • 10.3.1 STARS
    • 10.3.2 EMERGING LEADERS
    • 10.3.3 PERVASIVE
    • 10.3.4 EMERGING COMPANIES
    • FIGURE 25 NUCLEAR IMAGING EQUIPMENT MARKET: COMPETITIVE LEADERSHIP MAPPING (2019)
  • 10.4 COMPETITIVE SCENARIO
    • 10.4.1 PRODUCT LAUNCHES
    • TABLE 98 PRODUCT LAUNCHES (2017-2020)
    • 10.4.2 ACQUISITIONS
    • TABLE 99 ACQUISITIONS (2017-2020)
    • 10.4.3 AGREEMENTS, PARTNERSHIPS, & COLLABORATIONS
    • TABLE 100 AGREEMENTS, PARTNERSHIPS, & COLLABORATIONS (2017-2020)

11 COMPANY PROFILES

  • (Business overview, Products offered, Recent developments)**
  • 11.1 SIEMENS HEALTHINEERS
    • FIGURE 26 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2019)
  • 11.2 GE HEALTHCARE
    • FIGURE 27 GE HEALTHCARE: COMPANY SNAPSHOT (2019)
  • 11.3 KONINKLIJKE PHILIPS N.V.
    • FIGURE 28 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2019)
  • 11.4 DIGIRAD CORPORATION
  • 11.5 NEUSOFT MEDICAL SYSTEMS CO., LTD.
  • 11.6 CANON INC.
    • FIGURE 29 CANON INC.: COMPANY SNAPSHOT (2019)
  • 11.7 SURGICEYE GMBH
  • 11.8 DDD-DIAGNOSTIC A/S
  • 11.9 CMR NAVISCAN CORPORATION
  • 11.10 MEDISO LTD.
  • 11.11 SHIMADZU CORPORATION
    • FIGURE 30 SHIMADZU CORPORATION: COMPANY SNAPSHOT (2019)
  • 11.12 PERKINELMER, INC.
    • FIGURE 31 PERKINELMER, INC.: COMPANY SNAPSHOT (2018)
  • 11.13 MILABS B.V.
  • 11.14 MR SOLUTIONS LTD.
  • *Business overview, Products offered, Recent developments might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 AVAILABLE CUSTOMIZATIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS